Literature DB >> 33683571

Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue.

Varshasnata Mohanty1, Yashwanth Subbannayya1,2, Shankargouda Patil3, Vinuth N Puttamallesh4, Mohd Altaf Najar1, Keshava K Datta1, Sneha M Pinto1,2, Sameera Begum5, Neeta Mohanty6, Samapika Routray6,7, Riaz Abdulla5, Jay Gopal Ray8,9, David Sidransky10, Harsha Gowda1,4,11, T S Keshava Prasad12, Aditi Chatterjee13,14,15.   

Abstract

Loss of cell differentiation is a hallmark for the progression of oral squamous cell carcinoma (OSCC). Archival Formalin-Fixed Paraffin-Embedded (FFPE) tissues constitute a valuable resource for studying the differentiation of OSCC and can offer valuable insights into the process of tumor progression. In the current study, we performed LC-MS/MS-based quantitative proteomics of FFPE specimens from pathologically-confirmed well-differentiated, moderately-differentiated, and poorly-differentiated OSCC cases. The data were analyzed in four technical replicates, resulting in the identification of 2376 proteins. Of these, 141 and 109 were differentially expressed in moderately-differentiated and poorly differentiated OSCC cases, respectively, compared to well-differentiated OSCC. The data revealed significant metabolic reprogramming with respect to lipid metabolism and glycolysis with proteins belonging to both these processes downregulated in moderately-differentiated OSCC when compared to well-differentiated OSCC. Signaling pathway analysis indicated the alteration of extracellular matrix organization, muscle contraction, and glucose metabolism pathways across tumor grades. The extracellular matrix organization pathway was upregulated in moderately-differentiated OSCC and downregulated in poorly differentiated OSCC, compared to well-differentiated OSCC. PADI4, an epigenetic enzyme transcriptional regulator, and its transcriptional target HIST1H1B were both found to be upregulated in moderately differentiated and poorly differentiated OSCC, indicating epigenetic events underlying tumor differentiation. In conclusion, the findings support the advantage of using high-resolution mass spectrometry-based FFPE archival blocks for clinical and translational research. The candidate signaling pathways identified in the study could be used to develop potential therapeutic targets for OSCC.

Entities:  

Keywords:  Cancer grade; Cancer pathology; Molecular medicine; Pressure cycling technology; Quantitative proteomics; Tumor differentiation

Year:  2021        PMID: 33683571      PMCID: PMC8222490          DOI: 10.1007/s12079-021-00609-3

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  70 in total

Review 1.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Authors:  Mina J Bissell; William C Hines
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

2.  Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Zhefeng Xiao; Guoqing Li; Yongheng Chen; Maoyu Li; Fang Peng; Cui Li; Feng Li; Yanhui Yu; Yongmei Ouyang; Zhiqiang Xiao; Zhuchu Chen
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

3.  Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.

Authors:  Ayako Negishi; Mari Masuda; Masaya Ono; Kazufumi Honda; Miki Shitashige; Reiko Satow; Tomohiro Sakuma; Hideya Kuwabara; Yukihiro Nakanishi; Yae Kanai; Ken Omura; Setsuo Hirohashi; Tesshi Yamada
Journal:  Cancer Sci       Date:  2009-05-18       Impact factor: 6.716

Review 4.  Collagen as a double-edged sword in tumor progression.

Authors:  Min Fang; Jingping Yuan; Chunwei Peng; Yan Li
Journal:  Tumour Biol       Date:  2013-12-15

5.  Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.

Authors:  Wei Xiao; Ji Wang; Heng Li; Ding Xia; Gan Yu; Weimin Yao; Yang Yang; Haibing Xiao; Bin Lang; Xin Ma; Xiaolin Guo; Wei Guan; Hua Xu; Jihong Liu; Xu Zhang; Zhangqun Ye
Journal:  BMC Cancer       Date:  2014-09-18       Impact factor: 4.430

6.  Proteomic maps of breast cancer subtypes.

Authors:  Stefka Tyanova; Reidar Albrechtsen; Pauliina Kronqvist; Juergen Cox; Matthias Mann; Tamar Geiger
Journal:  Nat Commun       Date:  2016-01-04       Impact factor: 14.919

Review 7.  Lipid metabolism in cancer cells under metabolic stress.

Authors:  Rimsha Munir; Jan Lisec; Johannes V Swinnen; Nousheen Zaidi
Journal:  Br J Cancer       Date:  2019-05-16       Impact factor: 7.640

8.  The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function.

Authors:  Yashwanth Subbannayya; Markus Haug; Sneha M Pinto; Varshasnata Mohanty; Hany Zakaria Meås; Trude Helen Flo; T S Keshava Prasad; Richard K Kandasamy
Journal:  Int J Mol Sci       Date:  2020-12-29       Impact factor: 5.923

9.  Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.

Authors:  Sho Matsukawa; Kei-ichi Morita; Ayako Negishi; Hiroyuki Harada; Yusuke Nakajima; Hiroaki Shimamoto; Hirofumi Tomioka; Kae Tanaka; Masaya Ono; Tesshi Yamada; Ken Omura
Journal:  Cancer Med       Date:  2014-02-07       Impact factor: 4.452

Review 10.  Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer.

Authors:  Miguel Beato; Priyanka Sharma
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 6.208

View more
  1 in total

Review 1.  Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma.

Authors:  Yuhan Wang; Xiaoxin Zhang; Shuai Wang; Zihui Li; Xinyang Hu; Xihu Yang; Yuxian Song; Yue Jing; Qingang Hu; Yanhong Ni
Journal:  Biomolecules       Date:  2022-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.